Adiposity is associated with early reduction in bone mass in pediatric inflammatory bowel disease
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
UMass Chan Affiliations
Senior Scholars ProgramSchool of Medicine
Department of Quantitative Health Sciences
Department of Pediatrics
Document Type
Journal ArticlePublication Date
2016-01-21Keywords
ulcerative colitisCrohn’s disease
bone mineral density
adiposity
inflammation
Dietetics and Clinical Nutrition
Digestive System Diseases
Endocrinology, Diabetes, and Metabolism
Pediatrics
Metadata
Show full item recordAbstract
Background: The effect of adiposity on bone mass in the early phases of inflammatory bowel disease (IBD) in children and adolescents is unclear. Aims: To determine the role of adiposity on bone mass in the first 3 years of diagnosis of IBD. Hypothesis: Increased adiposity will be associated with increased bone mass in both the controls and IBD subjects. Setting: University tertiary institution. Methods: Height-adjusted bone mineral density (BMD) z-scores of 25 subjects, age 13.97 ± 2.70y, diagnosed with IBD for < 4 years were compared to 24 controls, age 13.65 ± 2.60y. Overweight was defined as BMI of ≥85th but <95th percentile, and obesity as BMI ≥95thpercentile. Severity of IBD was determined by the Pediatric Crohn’s Disease Activity Index and Lichtiger Colitis Activity Index. Results: Prior to stratification by BMI criterion, height-adjusted BMD z-scores were non-significantly lower in IBD subjects vs. controls for both the femoral neck (-0.8 ± 1.1 vs. -0.06 ± 1.1, p=0.070) and lumbar vertebrae (-0.4 ± 1.2 vs. 0.2 ± 1.2, p=0.086). Following stratification, height-adjusted BMD z-scores were significantly lower in the overweight/obese IBD subjects vs. overweight/obese controls for femoral neck (-0.9 ± 0.9 vs. 0.3 ± 1.3, p=0.032); and non-significantly lower for the lumbar spine z-score (-0.4 ± 1.6 vs. 0.5 ± 1.3, p=0.197). BMD z-score had no relationship with the duration of disease, steroid therapy, and the severity of disease. Conclusion: Adiposity was associated with reduced bone mass in the early phases of IBD, but with increased bone mass in the controls.Source
Setty-Shah N, Maranda L, Nwosu BU. Adiposity is associated with early reduction in bone mass in pediatric inflammatory bowel disease. Nutrition. 2016 Jul-Aug;32(7-8):761-6. doi: 10.1016/j.nut.2016.01.004. PubMed PMID: 27138109. Link to article on publisher's site
DOI
10.1016/j.nut.2016.01.004Permanent Link to this Item
http://hdl.handle.net/20.500.14038/43232PubMed ID
27138109Notes
Nithya Setty-Shah participated in this study as a medical student as part of the Senior Scholars research program at the University of Massachusetts Medical School.
Related Resources
Link to article in PubMedRights
This is a PDF file of an unedited manuscript that has been accepted for publication and posted with a 12 month embargo as allowed by the publisher's author rights policy at https://www.elsevier.com/about/company-information/policies/sharing.Distribution License
http://creativecommons.org/licenses/by-nc-nd/4.0/ae974a485f413a2113503eed53cd6c53
10.1016/j.nut.2016.01.004
Scopus Count
Collections
Except where otherwise noted, this item's license is described as This is a PDF file of an unedited manuscript that has been accepted for publication and posted with a 12 month embargo as allowed by the publisher's author rights policy at https://www.elsevier.com/about/company-information/policies/sharing.